Inverse relationship between serum total bilirubin levels and severity of disease in patients with stable coronary artery disease. 2013

Murat Turfan, and Mustafa Duran, and Fatih Poyraz, and Cagri Yayla, and Mehmet K Akboga, and Asife Sahinarslan, and Yusuf Tavil, and Hatice Pasaoglu, and Bulent Boyaci
Department of Cardiology, Faculty of Medicine, Bezmialem University, Istanbul, Turkey. turphan@gmail.com

OBJECTIVE Many studies have shown that bilirubin may protect against atherosclerosis. In the present study, we assess the association between serum total bilirubin levels and the severity of coronary artery disease (CAD) assessed by angiography and the Syntax score. METHODS Patients from our center, who visited the center for a coronary angiography, from January 2008 to January 2011, were eligible for this analysis. Serum bilirubin levels and other blood parameters in at least 12-h fasting states were determined. The patients were divided into tertiles according to their Syntax score. RESULTS A total of 299 patients were registered for the study. The total bilirubin levels in the low Syntax score group were significantly higher than those of the other groups. After multiple logistic regression analysis, serum bilirubin levels (odds ratio=0.155, 95% confidence interval, 0.039-0.62, P=0.008) were identified as independent correlates of a high Syntax score. CONCLUSIONS Serum bilirubin levels were independently and inversely associated with the severity of disease in patients with stable CAD. Serum total bilirubin level may be useful as a marker of the severity of CAD.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011237 Predictive Value of Tests In screening and diagnostic tests, the probability that a person with a positive test is a true positive (i.e., has the disease), is referred to as the predictive value of a positive test; whereas, the predictive value of a negative test is the probability that the person with a negative test does not have the disease. Predictive value is related to the sensitivity and specificity of the test. Negative Predictive Value,Positive Predictive Value,Predictive Value Of Test,Predictive Values Of Tests,Negative Predictive Values,Positive Predictive Values,Predictive Value, Negative,Predictive Value, Positive
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D003324 Coronary Artery Disease Pathological processes of CORONARY ARTERIES that may derive from a congenital abnormality, atherosclerotic, or non-atherosclerotic cause. Arteriosclerosis, Coronary,Atherosclerosis, Coronary,Coronary Arteriosclerosis,Coronary Atherosclerosis,Left Main Coronary Artery Disease,Left Main Coronary Disease,Left Main Disease,Arterioscleroses, Coronary,Artery Disease, Coronary,Artery Diseases, Coronary,Atheroscleroses, Coronary,Coronary Arterioscleroses,Coronary Artery Diseases,Coronary Atheroscleroses,Left Main Diseases
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D001663 Bilirubin A bile pigment that is a degradation product of HEME. Bilirubin IX alpha,Bilirubin, (15E)-Isomer,Bilirubin, (4E)-Isomer,Bilirubin, (4E,15E)-Isomer,Bilirubin, Calcium Salt,Bilirubin, Disodium Salt,Bilirubin, Monosodium Salt,Calcium Bilirubinate,Hematoidin,delta-Bilirubin,Bilirubinate, Calcium,Calcium Salt Bilirubin,Disodium Salt Bilirubin,Monosodium Salt Bilirubin,Salt Bilirubin, Calcium,delta Bilirubin
D012307 Risk Factors An aspect of personal behavior or lifestyle, environmental exposure, inborn or inherited characteristic, which, based on epidemiological evidence, is known to be associated with a health-related condition considered important to prevent. Health Correlates,Risk Factor Scores,Risk Scores,Social Risk Factors,Population at Risk,Populations at Risk,Correlates, Health,Factor, Risk,Factor, Social Risk,Factors, Social Risk,Risk Factor,Risk Factor Score,Risk Factor, Social,Risk Factors, Social,Risk Score,Score, Risk,Score, Risk Factor,Social Risk Factor

Related Publications

Murat Turfan, and Mustafa Duran, and Fatih Poyraz, and Cagri Yayla, and Mehmet K Akboga, and Asife Sahinarslan, and Yusuf Tavil, and Hatice Pasaoglu, and Bulent Boyaci
June 2017, Herz,
Murat Turfan, and Mustafa Duran, and Fatih Poyraz, and Cagri Yayla, and Mehmet K Akboga, and Asife Sahinarslan, and Yusuf Tavil, and Hatice Pasaoglu, and Bulent Boyaci
May 2007, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme,
Murat Turfan, and Mustafa Duran, and Fatih Poyraz, and Cagri Yayla, and Mehmet K Akboga, and Asife Sahinarslan, and Yusuf Tavil, and Hatice Pasaoglu, and Bulent Boyaci
March 2014, Angiology,
Murat Turfan, and Mustafa Duran, and Fatih Poyraz, and Cagri Yayla, and Mehmet K Akboga, and Asife Sahinarslan, and Yusuf Tavil, and Hatice Pasaoglu, and Bulent Boyaci
January 2015, Postepy w kardiologii interwencyjnej = Advances in interventional cardiology,
Murat Turfan, and Mustafa Duran, and Fatih Poyraz, and Cagri Yayla, and Mehmet K Akboga, and Asife Sahinarslan, and Yusuf Tavil, and Hatice Pasaoglu, and Bulent Boyaci
January 2016, Coronary artery disease,
Murat Turfan, and Mustafa Duran, and Fatih Poyraz, and Cagri Yayla, and Mehmet K Akboga, and Asife Sahinarslan, and Yusuf Tavil, and Hatice Pasaoglu, and Bulent Boyaci
October 2012, Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir,
Murat Turfan, and Mustafa Duran, and Fatih Poyraz, and Cagri Yayla, and Mehmet K Akboga, and Asife Sahinarslan, and Yusuf Tavil, and Hatice Pasaoglu, and Bulent Boyaci
October 2012, Archives of Iranian medicine,
Murat Turfan, and Mustafa Duran, and Fatih Poyraz, and Cagri Yayla, and Mehmet K Akboga, and Asife Sahinarslan, and Yusuf Tavil, and Hatice Pasaoglu, and Bulent Boyaci
September 2016, ARYA atherosclerosis,
Murat Turfan, and Mustafa Duran, and Fatih Poyraz, and Cagri Yayla, and Mehmet K Akboga, and Asife Sahinarslan, and Yusuf Tavil, and Hatice Pasaoglu, and Bulent Boyaci
March 2016, Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir,
Murat Turfan, and Mustafa Duran, and Fatih Poyraz, and Cagri Yayla, and Mehmet K Akboga, and Asife Sahinarslan, and Yusuf Tavil, and Hatice Pasaoglu, and Bulent Boyaci
January 2022, Frontiers in cardiovascular medicine,
Copied contents to your clipboard!